Korean J Urol.  2008 Dec;49(12):1140-1143.

Effect of Topical Steroids(0.05% Clobetasol Propionate) in Children with Phimosis

• Jung SG
• Bang SI
• Lee SD

Abstract

PURPOSE: We evaluated the effect of a topical steroid(0.05% clobetasol propionate[Dermovate(R)]) on phimosis.
MATERIALS AND METHODS
Between May 2005 and May 2007, 30 boys with phimosis were assigned to receive topical application of Dermovate(R). Of the 30 boys, 19 boys had concealed penises. The parents of the boys were instructed to retract the foreskin gently without causing pain, and to apply the topical steroid over the stenotic opening of the prepuce twice daily for 4 weeks then for another 4 weeks if no improvement was achieved. Retractibility of the prepuce was graded from 1-6. Response to treatment was arbitrarily defined as improvement in the retractibility score(complete response, score 5 and 6; partial response, score 3 and 4; no response, score 1 and 2). The effect of treatment was studied with respect to the duration of treatment, age, and an associated concealed penis.
RESULTS
The pretreatment grade in all patients was a retractibility score of 1. The mean age of the patients was 48.5+/-27.6 months(range, 7-108 months). The complete response rates in boys treated for 4 and 8 weeks were 50% and 73.3%, respectively. In boys younger than 3 years of age (n=12) and older than 3 years of age(n=18), the complete response rates were 75% and 72.2%, respectively(p=0.866). In boys with or without an associated concealed penis(n=19 and n=11, respectively), the complete response rates were 63.1% and 90.9%, respectively(p=0.199). No adverse effect was encountered in all patients.
CONCLUSIONS
Our data suggest that the application of topical steroids for 8 weeks as a first line treatment of phimosis may be effective, although further studies are needed to establish the definite efficacy and safety of this procedure.

Keyword

Phimosis; Clobetasol propionate

MeSH Terms

Child
Clobetasol
Female
Foreskin
Humans
Male
Parents
Penis
Phimosis
Steroids
Clobetasol
Steroids

Reference

References

1. Oster J. Further fate of the foreskin. Incidence of preputial adhesions, phimosis, and smegma among Danish school boy. Arch Dis Child. 1968; 43:200–3.

2. Schoen EJ, Colby CJ, Ray GT. Newborn circumcision decreases incidence and costs of urinary tract infections during the first year of life. Pediatrics. 2000; 105:789–93.

3. Chu CC, Chen KC, Diau GY. Topical steroid treatment of phimosis in boys. J Urol. 1999; 162:861–3.

4. Ozkan S, Gurpinar T. A serious circumcision complication: penile shaft amputation and a new reattachment technique with a successful outcome. J Urol. 1997; 158:1946–7.

5. Jorgensen ET, Svensson A. The treatment of phimosis in boys, with a potent topical steroid (clobetasol propionate 0.05%) cream. Acta Derm Venereol. 1993; 73:55–6.

6. Kikiros CS, Beasley SW, Woodward AA. The response of phimosis to local steroid application. Pediart Surg Int. 1993; 8:339–42.

7. Kayaba H, Tamura H, Kitajima S, Fujiwara Y, Kato T. Analysis of shape and retractibility of the prepuce in 603 Japanese boys. J Urol. 1996; 156:1813–5.

8. Wiswell TE, Tencer HL, Welch CA, Chamberlain JL. Circumcision in children beyond the neonatal period. Pediatrics. 1993; 92:791–3.

9. Herzog LW, Alvarez SR. The frequency of foreskin problems in uncircumcised children. Am J Dis Child. 1986; 140:254–6.

10. Rickwood AM, Walker J. Is phimosis overdiagnosed in boys and are too many circumcisions performed in consequence? Ann R Coll Surg Engl. 1989; 71:275–7.

11. Gordon A, Collin J. Save the normal foreskin. BMJ. 1993; 306:1–2.

12. Orsola A, Caffaratti J, Garat JM. Conservative treatment of phimosis in children using a topical steroid. Urology. 2000; 56:307–10.

13. Monsour MA, Rabinovitch HH, Dean GE. Medical management of phimosis in children: our experience with topical steroids. J Urol. 1999; 162:1162–4.

14. Wright JE. The treatment of childhood phimosis with topical steroid. Aust N Z J Surg. 1994; 64:327–8.

15. Voborilova V, Havranek P. Conservative treatment of phimosis in childhood. Rozhl Chir. 1997; 76:364–6.

16. Hepburn DJ, Aeling JL, Weston WL. A reappraisal of topical steroid potency. Pediatr Dermatol. 1999; 13:239–45.

17. Golubovic Z, Milanovic D, Vukadinovic V, Rakic I, Perovic S. The conservative treatment of phimosis in boys. Br J Urol. 1996; 78:786–8.

18. Yanagisawa N, Baba K, Yamagoe M, Iwamoto T. Conservative treatment of childhood phimosis with topical conjugated equine estrogen ointment. Int J Urol. 2000; 7:1–3.

19. Ng WT, Fan N, Wong CK, Leung SL, Yuen KS, Sze YS, et al. Treatment of childhood phimosis with a moderately potent topical steroid. ANZ J Surg. 2001; 71:541–3.

20. Ku WH, Chiu BS, Huen KF. Outcome and recurrence in treatment of phimosis using topical betamethasone in children in Hong Kong. J Paediatr Child Health. 2007; 43:74–9.

21. Lindhagen T. Topical clobetasol propionate compared with placebo in the treatment of unretractable foreskin. Eur J Surg. 1996; 162:969–72.

22. Elmore JM, Baker LA, Snodgrass WT. Topical steroid therapy as an alternative to circumcision for phimosis in boys younger than 3 years. J Urol. 2002; 168:1746–7.

23. Yang SS, Tsai YC, Wu CC, Liu SP, Wang CC. Highly potent and moderately potent topical steroids are effective in treating phimosis: a prospective randomized study. J Urol. 2005; 173:1361–3.

24. Ruud E, Holt J. Phimosis can be treated with local steroids. Tidsskr Nor Laegeforen. 1997; 117:513–4.